FDA, AstraZeneca and Breast Cancer
FDA Approves AstraZeneca's Datroway For Pretreated Breast Cancer Patients
On Friday, the U.S. Food and Drug Administration (FDA) approved AstraZeneca Plc’s (NASDAQ:AZN) Datroway (datopotamab deruxtecan or Dato-DXd) for adult patients with unresectable or metastatic hormone receptor (HR)-positive,
FDA approves Datroway for advanced breast cancer
The FDA approved datopotamab deruxtecan-dlnk for treatment of certain patients with advanced breast cancer.The indication applies to use of the agent by adults with hormone receptor-positive, HER2-negative breast cancer who received prior endocrine-based therapy and chemotherapy for unresectable or metastatic disease.
Kirk Herbstreit wasn’t able to hold back his emotions after Ohio State won the national championship on Monday night at ...
ESPN analyst Kirk Herbstreit was visibly emotional after his alma mater Ohio State defeated Notre Dame to win the national ...
Gabriela Dabrowski, international tennis doubles champion, thought breast lump suspicious, but doctors said otherwise. They ...
Former MTV host Ananda Lewis opens up about her stage 4 breast cancer journey, urging Black women to prioritize prevention ...
It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...
After getting a metastatic breast cancer diagnosis, you may experience anxiety and depression. Here are some ways to manage ...
The increase in breast cancer rates among younger patients is occurring as the incidence of other early-onset cancers — ...
A clinical trial demonstrates the effectiveness of telephone-delivered acceptance and commitment therapy (ACT) in reducing fatigue's interference with functioning and improving the quality of life for ...
Kirk Herbstreit revealed his wife's cancer diagnosis while talking about his emotional moment after the national title game.
As cancer treatment costs have increased, identifying and treating early-stage cancer sooner reduces expenses and improves ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback